The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

Allscripts Healthcare Solutions Inc

Nasdaq: MDRX
Last

(U.S.) $13.15

Today's change0.00 0.00%
Updated September 3 4:00 PM EDT. Delayed by at least 15 minutes.
 

Allscripts Healthcare Solutions Inc

Nasdaq: MDRX
Last

(U.S.) $13.15

Today's change0.00 0.00%
Updated September 3 4:00 PM EDT. Delayed by at least 15 minutes.

Allscripts Healthcare Solutions Inc closed at (U.S.)$13.15.

Shares have lost 3.87% over the last five days, but are unchanged over the last year to date. This security has underperformed the S&P 500 by 9.06% during the last year.

Key company metrics

  • Open(U.S.) $0.00
  • Previous close(U.S.) $13.15
  • High--
  • Low--
  • Bid / Ask(U.S.) $11.50 / (U.S.) $15.39
  • YTD % change+2.98%
  • Volume0
  • Average volume (10-day)3,549,895
  • Average volume (1-month)3,510,841
  • Average volume (3-month)3,192,327
  • 52-week range(U.S.) $11.00 to (U.S.) $15.41
  • Beta0.96
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forward28.59×
  • Forward PEG1.01×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$0.23
Updated September 3 4:00 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
-3.00%

Although this company's net profit margin is negative, it is above the industry average and implies that Allscripts Healthcare Solutions Inc is operating more effectively than other companies in the industry.
Company Books

S&P TSX0.00%Sector:HealthcareIndustry:Advanced Medical Equipment
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2015Q1/2015Q4/2014Q3/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014Sep 30, 201409/30/2014
Revenue352335341345
Total other revenue--------
Total revenue352335341345
Gross profit144130136131
Total cost of revenue208205205214
Total operating expense346340340364
Selling / general / administrative87828597
Research & development44474246
Depreciation / amortization7797
Interest expense (income), net operating--------
Unusual expense (income)0000
Other operating expenses, total--------
Operating income6-61-19
Interest income (expense), net non-operating-4-4-4-4
Gain (loss) on sale of assets--------
Other--------
Income before tax-2-11-7-26
Income after tax-3-10-2-26
Income tax, total1-1-40
Net income-3-10-2-26
Total adjustments to net income--------
Net income before extra. items-3-10-2-26
Minority interest0------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-3-10-2-26
Inc. avail. to common incl. extra. items-3-10-2-26
Diluted net income-3-10-2-26
Dilution adjustment--------
Diluted weighted average shares182181180180
Diluted EPS excluding extraordinary itemsvalue per share-0.02-0.06-0.01-0.14
Dividends per sharevalue per share0.000.00--0.00
Diluted normalized EPSvalue per share-0.02-0.06-0.01-0.14